CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Henry E. Blair, Chairman and Chief Executive Officer of Dyax, will present at the 25th Annual JPMorgan Healthcare Conference, being held on January 8-11 at the Westin St. Francis in San Francisco. Mr. Blair will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax Corp. presentation is scheduled for Wednesday, January 10 at 2:30 pm (PT).
